Clinical and Demographic Factors Associated With Receipt of Non Guideline-concordant Initial Therapy for Nonmetastatic Prostate Cancer.

CONCLUSIONS:: Receipt of less aggressive therapy than indicated among high-risk group men with >5-year LE based on life table estimates adjusted for comorbidity was a concern. Physicians may tend to underestimate 5-year survival among this group and should be alerted to the importance of recommending aggressive therapy when warranted. However, based on more recent guidelines, among those with low-risk disease, the proportion considered to be receiving less aggressive therapy than indicated may now be lower because active surveillance is now considered appropriate. PMID: 24390274 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24390274?dopt=Abstract

Source: Clinical Breast Cancer - January 1, 2014 Category: Cancer & Oncology Authors: Hamilton AS, Fleming ST, Wang D, Goodman M, Wu XC, Owen JB, Lo M, Ho A, Anderson RT, Thompson T Tags: Am J Clin Oncol Source Type: research